CDC: “Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in the United States.”
Blanka Kaplan, MD, adult and pediatric allergy and immunology specialist, Northwell Health, Great Neck, NY.
Aaron E. Glatt, MD, chief, infectious diseases and hospital epidemiologist, Mount Sinai South Nassau; professor of medicine, Icahn School of Medicine at Mount Sinai, Oceanside, NY.
Tara Vijayan, MD, infectious disease specialist and assistant professor of medicine, UCLA David Geffen School of Medicine.
Martin Floreani, president and CEO, Dentovations, Boston.
The Journal of the American Medical Association: “Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine.”
Prostate: “Effect of 25-hydroxyvitamin D status on serological response to influenza vaccine in prostate cancer patients.”
Viruses: “Baseline Serum Vitamin A and D Levels Determine Benefit of Oral Vitamin A&D Supplements to Humoral Immune Responses Following Pediatric Influenza Vaccination.”